In summary, JUN and CCL20 had been identified as key targets for mediating the onset of NAFLD and leading to its progression from SS to NASH, and may be markers for predicting disease progression. The gene discussed is CCL20; the disease is metabolic dysfunction-associated steatohepatitis.